Caribou Biosciences, Inc. Business Finance Contracts & Agreements
17 Contracts & Agreements
- Assignment Agreements (4 contracts)
- Investor Rights Agreements (1)
- Note Agreements (1)
- Participation Agreements (3)
- Security Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (2)
- Underwriting Agreement, dated July 13, 2023, by and among the Company, BofA Securities, Inc., SVB Securities LLC, and Evercore Group L.L.C (Filed With SEC on July 17, 2023)
- Description of Common Stock (Filed With SEC on March 21, 2022)
- 2021 Employee Stock Purchase Plan (Filed With SEC on July 19, 2021)
- Form of Underwriting Agreement (Filed With SEC on July 19, 2021)
- Public Offering Participation Rights Agreement, dated March 2, 2021, by and between the Registrant and Zone III Healthcare Holdings, LLC (Filed With SEC on July 1, 2021)
- Public Offering Participation Rights Agreement, dated March 2, 2021, by and between the Registrant and Ridgeback Capital Investments LP (Filed With SEC on July 1, 2021)
- Public Offering Participation Rights Agreement, dated March 2, 2021, by and between the Registrant and PFM Health Sciences, LP (Filed With SEC on July 1, 2021)
- Series C Preferred Stock Purchase Agreement, dated March 2, 2021, by and among the Registrant and the parties listed therein (Filed With SEC on July 1, 2021)
- Pledge and Security Agreement, dated November 27, 2018, by and between the Registrant and Rachel E. Haurwitz, Ph.D (Filed With SEC on July 1, 2021)
- Promissory Note, dated November 27, 2018 made by Rachel E. Haurwitz, Ph.D. in favor of the Registrant (Filed With SEC on July 1, 2021)
- Form of Stock Option Agreement under the 2012 Stock Option/Stock Issuance Plan (Filed With SEC on July 1, 2021)
- 2012 Stock Option/Stock Issuance Plan of the Registrant (Filed With SEC on July 1, 2021)
- Amendment No. 3 to Sale and Assignment Agreement dated May 5, 2020, by and between the Registrant and ProMab Biotechnologies, Inc (Filed With SEC on July 1, 2021)
- Amendment No. 2 to Sale and Assignment Agreement dated as of December 15, 2020, by and between the Registrant and ProMab Biotechnologies, Inc (Filed With SEC on July 1, 2021)
- Amendment No. 1 to Sale and Assignment Agreement dated as of October 20, 2020, by and between the Registrant and ProMab Biotechnologies, Inc (Filed With SEC on July 1, 2021)
- Sale and Assignment Agreement, dated as of January 31, 2020, by and between the Registrant and ProMab Biotechnologies, Inc (Filed With SEC on July 1, 2021)
- Second Amended and Restated Investors Rights Agreement, dated March 2, 2021, by and among the Registrant and the investors listed therein (Filed With SEC on July 1, 2021)
